Ketamine experience of Zoe Boyer published in the NY Times

Ketamine experience of Zoe Boyer published in the NY Times

Ever since the efficiency of Ketamine in the treatment of depression (among other health conditions) proved to be more and more apparent, public interest for this treatment option and experiences of people, who were treated with it, are on a constant rise. One such example is the experience of Zoe Boyer, a writer who began her treatment for depression with ketamine in 2016, published in NY Times.

Treatment-resistant Depression Disorder

By the time she was 26 years old, Zoe was already suffering from severe depression and had to move into her parent’s home because she was no longer able to care for herself. Even the most ease and mundane of tasks appeared to be insurmountable, and she would spend days on the couch with her mind so dull that she rarely spoke and struggled to form words.

The onset of Zoe’s illness was in early childhood, and she had been unable to resurface to ‘normal’ ever since.  Her days were filled with dread and immutable sadness, and this once excellent student was now struggling to make it through school and eventually dropped out at the age of 16.

Zoe tried every treatment that was available to her — numerous antidepressants, inpatient psychiatric admissions, and extensive counseling — without any relief.

Zoe’s experience with Ketamine

Zoe’s life changed when she stumbled upon an article that described novel usage of ketamine as a promising treatment for unresponsive and severe depression. The only problem was the price tag of $500 per infusion at that time.

After consulting with her therapist, Zoe applied for ketamine treatments at a clinic that was offering this therapy. Though all other treatment options had proven unsuccessful hope existed, because a screening determined her to be a good candidate for ketamine therapy.

Her initial ketamine treatment plan consisted of six infusions administered over the course of two weeks. After this initial treatment, she was instructed to return for maintenance doses on a per need basis, which she was advised might mean returning anywhere between once each one to six months.

During the first few minutes her first infusion, Zoe felt nothing.  Then her vision suddenly became wavy, and she felt a pleasant, very mild alteration.

Each subsequent session was with an increased ketamine dosage, until Zoe reported that she felt as if the room around her was dissolving while she seemed to travel back in time by revisiting memories while also feeling pleasantly detached.

Zoe didn’t feel her depression subside immediately, though she did feel more at peace after every treatment. Some suggested that it might not be worth the cost to continue after a third treatment showed no results.  Not deterred, she continued with treatment and found results began to appear after her fourth infusion. Zoe felt as though some switch had been flipped, lighting up her brain and letting color back into her world.  The hard knot of lack of passion and dread that she had felt in her chest finally dissolved.

Her productivity increased all of a sudden.  She reorganized and cleaned her apartment, applied for a few jobs and got hired, started meditating and studying a new language, all within a few weeks.

In May 2021, five years after she began her first ketamine treatment and fifteen years after had she dropped out of high school, Zoe graduated from college.

While Ketamine doesn’t work for everyone, for many, like Zoe, it does. If you are suffering from a treatment-resistant condition, a chronic pain or mental health issue, contact us for a free consultation. We will discuss your situation and determine if ketamine infusion is a viable treatment option for your specific case.

Share Now :